Evecxia Therapeutics Announces CEO Transition
Evecxia Therapeutics, Inc., the leader in serotonin synthesis amplification to treat brain disorders, today announced that Dr. Jacob Jacobsen has been appointed President and CEO.
- Evecxia Therapeutics, Inc., the leader in serotonin synthesis amplification to treat brain disorders, today announced that Dr. Jacob Jacobsen has been appointed President and CEO.
- Dr. Jacobsen succeeds Joseph Patti, Ph.D., who has stepped down from his role as President and CEO of Evecxia to pursue other interests.
- While a scientist at Duke University, he co-founded Evecxia with the late James B Duke Professor, Dr. Marc Caron.
- “I am excited to be leading Evecxia at this pivotal time in the Company’s history,” said Dr. Jacobsen.